Effects of triton WR-1339 on blood-lipids of mice

Chinese Pharmacological Bulletin

Volumn 18, Issue 5, 2002, Pages 599-600

  Yu, Yan Hui ^a   Wen, Jun ^a   Guo, Zhao Gui ^a  

^a Central South University   (China)

Author keywords

Blood lipids; Hyperlipidemia; Mouse; Triton WR 1339

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TYLOXAPOL;

ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MOUSE; NONHUMAN;

EID: 0036816325     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Hirsch RL, Aaron K. The pathogenesis of hyperlipemia induced by meas of surface-active agents. I. Increased total body TC lesterol in mice given triton WR-1339 parenterally. II. Failure of exchange of chloesterol between the plasma and the liver in rabbits given triton WR-1339. J Exp Med, 1956;104(1):1-25
2. Martin MJ, Hulley BS, Browner SW et al. Serum TClesterol, blood pressure and mortality: Implications from a cohat of 361 662 men. Lancet, 1986;2(8513):933-6
3. Jeppesen J, Hein HO, Suadicani P et al. Triglyceride concentration and ischemic heart disease: An eight-year follow-up in the Copenhagen Male study. Circulation, 1998;97(11):1029-36
4. Anber V, Griffin BA, McConnell M et al. Influence of plasma lipid and LDL-C-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans. Atherosclerosis, 1996;124(2):261-71
5. Arisake O, Fujiwara S, Yabuta K et al. Characterization of low-density lipoprotein subclasses in children. Metabolism, 1997;46 (2):146-8
6. Nissen H, Hansen PS, Faergeman O et al. Mutation screening of the codon 3500 region of the apolipoprotein B gene by denaturing gradient-gel electrophoresis. Clin Chem, 1995;41(3):419-23